Correlation Between Viracta Therapeutics and TNF Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viracta Therapeutics and TNF Pharmaceuticals,, you can compare the effects of market volatilities on Viracta Therapeutics and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and TNF Pharmaceuticals,.

Diversification Opportunities for Viracta Therapeutics and TNF Pharmaceuticals,

0.71

Correlation Coefficient

Viracta Therapeutics  TNF Pharmaceuticals,

Poor diversification

The 3 months correlation between Viracta and TNF is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Viracta Therapeutics and TNF Pharmaceuticals,

Given the investment horizon of 90 days Viracta Therapeutics is expected to generate 1.67 times less return on investment than TNF Pharmaceuticals,. But when comparing it to its historical volatility, Viracta Therapeutics is 1.52 times less risky than TNF Pharmaceuticals,. It trades about 0.03 of its potential returns per unit of risk. TNF Pharmaceuticals, is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  134.00  in TNF Pharmaceuticals, on September 24, 2024 and sell it today you would lose (5.00) from holding TNF Pharmaceuticals, or give up 3.73% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Viracta Therapeutics  vs.  TNF Pharmaceuticals,

Viracta Therapeutics

Risk-Adjusted Performance

2 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Viracta Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Viracta Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

TNF Pharmaceuticals,

Risk-Adjusted Performance

2 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in TNF Pharmaceuticals, are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady technical and fundamental indicators, TNF Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Viracta Therapeutics and TNF Pharmaceuticals,

The main advantage of trading using opposite Viracta Therapeutics and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.

The idea behind Viracta Therapeutics and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .